Pharmstandard International S.A., 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 31,704 shares at $4.69 ($150K) on 2016-10-04, disclosed to the SEC on 2016-10-13.
Open-market purchase of $150k ARGS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.69 | 7,164 | $34K | 22.4% |
| 2 | $4.85 | 900 | $4K | 2.9% |
| 3 | $4.81 | 2,640 | $13K | 8.5% |
| 4 | $4.73 | 21,000 | $99K | 66.2% |
| Total | $4.73 avg | 31,704 | $150K | 100% |
| Filing → |
| ARGS | BUY | 2016-08-29 | $252K | — | Filing → |
| ARGS | BUY | 2016-08-25 | $305K | — | Filing → |
| ARGS | BUY | 2016-08-23 | $320K | — | Filing → |